导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.36% | 954/1050 |
| 近一周 | -2.38% | 578/1104 |
| 近一月 | -2.86% | 332/1102 |
| 近一季 | -0.71% | 278/1092 |
| 近半年 | -13.87% | 862/1070 |
| 近一年 | -28.10% | 978/1018 |
| 近两年 | 5.84% | 861/926 |
| 近三年 | -27.37% | 800/834 |
| 成立以来 | 40.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.64% 933/1070 |
-14.41% 1006/1101 |
- - |
- - |
| 2025 | 3.26% 907/1065 |
4.67% 431/1014 |
9.84% 108/1038 |
0.29% 997/1050 |
-10.44% 892/1065 |
| 2024 | 0.65% 564/1011 |
-0.45% 338/960 |
-10.84% 889/983 |
15.55% 200/991 |
-1.86% 438/1011 |
| 2023 | -26.13% 781/952 |
3.53% 404/880 |
-17.46% 869/895 |
-1.21% 125/915 |
-12.50% 903/952 |
| 2022 | -14.82% 166/867 |
-18.05% 428/773 |
17.67% 59/806 |
-14.91% 560/845 |
3.82% 250/867 |
| 2021 | -0.63% 357/740 |
0.08% 147/580 |
9.87% 360/659 |
-13.09% 577/704 |
3.98% 261/740 |
| 2020 | 98.56% 36/554 |
-5.11% 292/419 |
30.80% 118/466 |
25.67% 16/517 |
27.30% 48/554 |
| 2019 | - - |
- - |
- - |
3.37% 238/390 |
7.02% 276/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实消费精选股票A VS. 东吴新产业精选股票A(580008) |